Grand Pharmaceutical Group (SEHK:512) Balance Sheet Analysis 2004-2025

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Metric	2024	2025
Total Cash And Short-Term Investments	HK$3.141B	HK$2.089B
Net Receivables	HK$2.786B	HK$4.734B
Inventory	HK$1.371B	HK$1.484B
Prepaid Expenses And Other Current Assets	HK$591.333M	-
Other Current Assets	HK$136.237M	-
Total Current Assets	HK$8.026B	HK$8.308B
Property, Plant And Equipment	HK$3.836B	HK$4.824B
Goodwill And Intangible Assets	HK$3.813B	HK$4.946B
Long-Term Investments	HK$6.239B	HK$7.991B
Deferred Tax Assets	HK$33.456M	HK$70.632M
Other Noncurrent Assets	HK$3.045B	HK$1.027B
Total Noncurrent Assets	HK$16.966B	HK$18.859B
Other Assets	-	-
Total Assets	HK$24.991B	HK$27.167B

Metric	2024	2025
Total Payables	HK$1.459B	HK$2.014B
Accrued Expenses	-	-
Short-Term Debt	HK$3.127B	HK$2.841B
Current Portion Of Lease Obligations	HK$18.315M	-
Income Taxes Payable	HK$338.487M	-
Current Deferred Revenue	-	HK$323.926M
Other Current Liabilities	HK$1.969B	HK$2.137B
Total Current Liabilities	HK$6.573B	HK$7.317B
Long-Term Debt	HK$1.216B	HK$1.8B
Capital Lease Obligations	HK$58.919M	HK$40.277M
Noncurrent Deferred Revenue	HK$295.369M	HK$316.305M
Noncurrent Deferred Tax Liabilities	HK$300.351M	HK$367.265M
Other Noncurrent Liabilities	-	-
Total Noncurrent Liabilities	HK$1.893B	HK$2.565B
Other Liabilities	-	-
Total Liabilities	HK$8.466B	HK$9.881B

Metric	2024	2025
Treasury Stock	HK$-268.503M	-
Preferred Stock	-	-
Common Stock	HK$35.496M	HK$35.496M
Retained Earnings	HK$10.304B	-
Additional Paid-In Capital	HK$6.644B	-
Accumulated Other Comprehensive Income	HK$-242.266M	-
Other Stockholders' Equity	-	HK$16.982B
Total Common Stockholders' Equity	HK$16.473B	HK$17.017B
Minority Interest	HK$52.128M	HK$162.646M
Total Equity	HK$16.525B	HK$17.18B
Total Liabilities And Equity	HK$24.991B	HK$27.167B

Metric	2024	2025
Total Investments	HK$8.039B	HK$8.915B
Total Debt	HK$4.443B	HK$4.722B
Net Debt	HK$3.102B	HK$3.557B

Grand Pharmaceutical Group Balance Sheet

Balance Sheet Composition